Clinical Trial Update: Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing KTd vs KRd induction therapy in newly diagnosed multiple myeloma and investigating a K-mono maintenance strategy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• KRd
• KTd

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED